- Home
- CALC vs HCAI Comparison
CALC vs HCAI Comparison
Compare CALC & HCAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- HCAI
- Stock Information
- Founded
- CALC 2011
- HCAI 2004
- Country
- CALC United States
- HCAI China
- Employees
- CALC N/A
- HCAI N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- HCAI Miscellaneous manufacturing industries
- Sector
- CALC Health Care
- HCAI Consumer Discretionary
- Exchange
- CALC Nasdaq
- HCAI Nasdaq
- Market Cap
- CALC 32.4M
- HCAI 35.4M
- IPO Year
- CALC N/A
- HCAI 2025
- Fundamental
- Price
- CALC $3.80
- HCAI $0.83
- Analyst Decision
- CALC Strong Buy
- HCAI
- Analyst Count
- CALC 2
- HCAI 0
- Target Price
- CALC $14.50
- HCAI N/A
- AVG Volume (30 Days)
- CALC 133.2K
- HCAI 174.3K
- Earning Date
- CALC 08-11-2025
- HCAI 01-01-0001
- Dividend Yield
- CALC N/A
- HCAI N/A
- EPS Growth
- CALC N/A
- HCAI N/A
- EPS
- CALC N/A
- HCAI 0.05
- Revenue
- CALC N/A
- HCAI $40,944,770.00
- Revenue This Year
- CALC N/A
- HCAI N/A
- Revenue Next Year
- CALC N/A
- HCAI N/A
- P/E Ratio
- CALC N/A
- HCAI $16.62
- Revenue Growth
- CALC N/A
- HCAI 19.45
- 52 Week Low
- CALC $1.42
- HCAI $0.71
- 52 Week High
- CALC $5.97
- HCAI $10.97
- Technical
- Relative Strength Index (RSI)
- CALC 73.90
- HCAI N/A
- Support Level
- CALC $3.37
- HCAI N/A
- Resistance Level
- CALC $4.26
- HCAI N/A
- Average True Range (ATR)
- CALC 0.41
- HCAI 0.00
- MACD
- CALC 0.21
- HCAI 0.00
- Stochastic Oscillator
- CALC 82.80
- HCAI 0.00
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About HCAI Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares
Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider. The company manufactures and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.